Myeloid derived suppressor cells in human diseases
Authors:
- 1 July 2011
- journal article
- review article
- Published by Elsevier in International Immunopharmacology
- Vol. 11 (7) , 802-807
Abstract
No abstract availableKeywords
Funding Information
- Initiative and Networking Fund of the Helmholtz Association
- Intramural Research Program of the Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health
This publication has 70 references indexed in Scilit:
- HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironmentJournal of Experimental Medicine, 2010
- The biology of myeloid‐derived suppressor cells: The blessing and the curse of morphological and functional heterogeneityEuropean Journal of Immunology, 2010
- Immunosuppressive CD14+HLA‐DRlow/− monocytes in prostate cancerThe Prostate, 2009
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T CellsGastroenterology, 2008
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapyCancer Immunology, Immunotherapy, 2008
- Lung cancer patients’ CD4+ T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cellsCancer Immunology, Immunotherapy, 2008
- Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancerNature Medicine, 2007
- MyD88-dependent expansion of an immature GR-1+CD11b+ population induces T cell suppression and Th2 polarization in sepsisJournal of Experimental Medicine, 2007
- Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell functionJournal of Experimental Medicine, 2006